Reversin 121

Names

[ Name ]:
Reversin 121

Biological Activity

[Description]:

Reversin 121 is a P-glycoprotein inhibitor. Reversin 121 increases the ATPase activity of MDR1. Reversin 121 reverses P-glycoprotein-mediated multidrug resistance. Reversin 121 can be used in the research of cancers[1][2].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Membrane Transporter/Ion Channel >> P-glycoprotein

[Target]

P-glycoprotein[1]

[In Vitro]

Reversin 121 (12 μg/mL) (with gemcitabine (HY-17026)) reduces the proportions of tumor cells positive for MDR proteins in Panc1 cell[1]. Reversin 121 (5 μM) reverses the resistance against paclitaxel in paclitaxel-resistant NCI-H460 cell[2]. Reversin 121 (10 μM, 48 h) inhibits T cell proliferation[3].

[In Vivo]

Reversin 121 (2.5 mg/kg, plus 5-fluorouracil, 35 mg/kg/day, i.p.) decreases tumor size and prevalence of metastases[1]. Animal Model: Orthotopic pancreatic carcinoma mouse model[1]. Dosage: 2.5 mg/kg, plus 5-fluorouracil, 35 mg/kg/day Administration: Intraperitoneal injection (i.p.), 5 days a week Result: Decreased in MRP3-positive cells.

Chemical & Physical Properties

[ Molecular Formula ]:
C₃₄H₄₇N₃O₉

[ Molecular Weight ]:
641.75200

[ Exact Mass ]:
641.33100

[ PSA ]:
168.83000

[ LogP ]:
6.18550

Reversin 121

Names

Biological Activity

Chemical & Physical Properties

Related Compounds